Global Rapid Influenza Diagnostic Tests Market 2017-2021

  • ID: 4390882
  • Report
  • Region: Global
  • 74 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Alere
  • BD
  • bioMérieux
  • CorisBioconcept
  • Meridian Bioscience
  • Quidel
  • MORE
About Rapid Influenza Diagnostic Tests

RIDT is an antigen-based diagnostic test used for diagnosis of influenza virus infections in point-of-care (POC) settings. It employs lateral flow technique called immunochromatographic assays. RIDTs are available in the market in the form of a dipstick, card, and cassette. The instrument completes the test in less than 30 minutes and is commonly used for the diagnosis of influenza infections. Based on product type, global RIDTs market is segmented into RIDTs for influenza A and RIDTs for influenza B.

The analysts forecast the global rapid influenza diagnostic tests market to grow at a CAGR of 9.06% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global rapid influenza diagnostic tests market for 2017-2021. To calculate the market size, the report considers revenue generated by the sales of RIDTs.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Rapid Influenza Diagnostic Tests Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Alere
  • BD
  • Quidel
Other prominent vendors
  • bioMérieux
  • CorisBioconcept
  • Meridian Bioscience
  • Response Biomedical (acquired by OrbiMed)
  • Princeton BioMeditech Corporation
  • SA Scientific
  • Sekisui Diagnostics
  • Thermo Fisher Scientific
Market drivers
  • Government initiatives to control and prevent influenza
  • For a full, detailed list, view the full report
Market challenges
  • Product safety features of the test kits
  • For a full, detailed list, view the full report
Market trends
  • Rising technological advancements in diagnostics
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Alere
  • BD
  • bioMérieux
  • CorisBioconcept
  • Meridian Bioscience
  • Quidel
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Market outline
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Market segmentation by product
  • Market overview
  • RIDTs for influenza A
  • RIDTs for influenza B
PART 07: Market segmentation by end-user
  • Market overview
  • Hospitals and diagnostic laboratories
  • Academic and research centers
  • Homecare
PART 08: Geographical segmentation
  • Market overview
  • RIDTs market in Americas
  • RIDTs market in EMEA
  • RIDTs market in APAC
PART 09: Decision framework

PART 10: Drivers and challenges
  • Market drivers
  • Market challenges
PART 11: Market trends
  • Rising technological advancements in diagnostics
  • Increasing R&D investment
PART 12: Vendor landscape
  • Competitive landscape
  • Other prominent vendors
PART 13: Key vendor analysis
  • Alere
  • BD
  • Quidel
PART 14: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Global RIDTs market 2016-2021 ($ billions)
Exhibit 02: Five forces analysis
Exhibit 03: Global RIDTs market for influenza A 2016-2021 ($ billions)
Exhibit 04: Global RIDTs market for influenza B 2016-2021 ($ billions)
Exhibit 05: Segmentation of global RIDTs market by end-users 2016 (%)
Exhibit 06: Segmentation of global RIDTs market by end-users 2021 (%)
Exhibit 07: Global RIDTs market for hospitals and diagnostic laboratories 2016-2021 ($ billions)
Exhibit 08: Global RIDTs market for academic and research institutes 2016-2021 ($ billions)
Exhibit 09: Global RIDTs market for homecare 2016-2021 ($ billions)
Exhibit 10: Segmentation of global RIDTs market by geography 2016 (%)
Exhibit 11: Segmentation of global RIDTs market by geography 2021 (%)
Exhibit 12: RIDTs market overview in US
Exhibit 13: RIDTs market in Americas 2016-2021 ($ billions)
Exhibit 14: RIDTs market overview in UK
Exhibit 15: RIDTs market in EMEA 2016-2021 ($ billions)
Exhibit 16: RIDTs market overview in the Japan.
Exhibit 17: RIDTs market in APAC 2016-2021 ($ billions)
Exhibit 18: Factors driving the growth of POCT
Exhibit 19: People who are at high risk of influenza infection
Exhibit 20: Alere: Key highlights
Exhibit 21: Alere: Strength assessment
Exhibit 22: Alere: Strategy assessment
Exhibit 23: Alere: Opportunity assessment
Exhibit 24: BD: Key highlights
Exhibit 25: BD: Strength assessment
Exhibit 26: BD: Strategy assessment
Exhibit 27: BD: Opportunity assessment
Exhibit 28: Quidel: Key highlights
Exhibit 29: Quidel: Strength assessment
Exhibit 30: Quidel: Strategy assessment
Exhibit 31: Quidel: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Alere
  • BD
  • bioMérieux
  • CorisBioconcept
  • Meridian Bioscience
  • Quidel
  • MORE
New Report Released: - Global Rapid Influenza Diagnostic Tests Market 2017-2021

The author of the report recognizes the following companies as the key players in the global rapid influenza diagnostic tests market: Alere, BD, and Quidel.

Other Prominent Vendors in the market are: bioMérieux, CorisBioconcept, Meridian Bioscience, Response Biomedical, Princeton BioMeditech Corporation, SA Scientific, Sekisui Diagnostics, and Thermo Fisher Scientific.

Commenting on the report, an analyst from the research team said: “One trend in the market is rising technological advancements in diagnostics. The current healthcare market is shifting toward novel technology based, cost-effective devices in the diagnostic industry. There is an increasing number of manufacturers focusing on developing new-generation POC influenza tests such as LoC/microchip technology based on microelectromechanical system (MEMS). This technology mainly focusses on biological and chemical applications.”

According to the report, one driver in the market is government initiatives to control and prevent influenza. Pandemic influenza poses a risk of human health. For instance, the recent emergence of influenza A (H1N1) virus had led to a global influenza pandemic. As a result, there is increased requirement for diagnostic tests for influenza globally. Sophisticated influenza tests are available only in specialized laboratories. However, at the time of pandemic, their capacity may be overwhelming. Hence the use of RIDTs is preferred, especially in a remote setting without laboratory services. The RIDTs can be performed by healthcare professionals and test result can be obtained within 15-30 minutes.

Further, the report states that one challenge in the market is product safety features of the test kits. Product safety features of any diagnostic tests are highly recommended to measure the efficacy and acceptability of a product. The product safety features ensure that the product is suitable for the consumers. Also, it ensures guarantee to the consumers that they are compliant with international standards. The regulatory organizations dealing with testing of the product features entitle the manufacturers to display specific mark accepted in particular country. For instance, there is Warnock Hersey (WH) and Normas Oficiales Mexicanas (NOM) mark in the US and Mexico, and GS and ASTA mark in Europe.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Alere
  • BD
  • Quidel
  • bioMérieux
  • CorisBioconcept
  • Meridian Bioscience
  • Response Biomedical
  • Princeton BioMeditech Corporation
  • SA Scientific
  • Sekisui Diagnostics
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll